Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial.

Christina Baggott Jo Katherine Hardy Jenny Sparks Mark Holliday Daniela Hall Alexandra Vohlidkova Robert J Hancox Mark Weatherall James Fingleton Richard Beasleynull null

Published in: The European respiratory journal (2020)

The timing of ICS dose when self-titrated to β2-agonist use is more important than total ICS dose in reducing severe exacerbation risk in mild asthma, when associated with greater overall use of as-needed β2-agonist.

Keyphrases

chronic obstructive pulmonary disease
lung function
allergic rhinitis
study protocol
cystic fibrosis
clinical trial
randomized controlled trial
sleep quality
depressive symptoms
intensive care unit
physical activity
air pollution
acute respiratory distress syndrome
double blind